| UIGRX | VIGIX | UIGRX / VIGIX | |
| Total Expense Ratio | 0.91 | 0.03 | 3,033% |
| Annual Report Gross Expense Ratio | 0.92 | 0.03 | 3,067% |
| Fund Existence | 18 years | 28 years | - |
| Gain YTD | 1.630 | 7.482 | 22% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.44B | 379B | 1% |
| Annual Yield % from dividends | 0.00 | 0.39 | - |
| Returns for 1 year | -0.27 | 18.72 | -1% |
| Returns for 3 years | 29.48 | 81.35 | 36% |
| Returns for 5 years | 5.76 | 78.69 | 7% |
| Returns for 10 years | 65.52 | 374.95 | 17% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SLYV | 107.83 | 0.15 | +0.14% |
| State Street® SPDR® S&P 600™ Sm CpValETF | |||
| IBTO | 23.92 | N/A | N/A |
| iShares iBonds Dec 2033 Term Trsy ETF | |||
| THNR | 25.64 | -0.29 | -1.11% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| WLDR | 45.25 | -0.64 | -1.39% |
| Affinity World Leaders Equity ETF | |||
| COLO | 43.66 | -0.62 | -1.40% |
| Global X MSCI Colombia ETF | |||